Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menopausal Sleep Fragmentation and Body Fat Gain Biomarkers
NCT03047330Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jul 2017
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Brigham and Women's Hospital. Primary endpoint: Normalized Serum Leptin Levels at 5 weeks. Started Jul 2017; status: completed.
Beyond the preview
Go deeper on NCT03047330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03047330.